Scientists develop a new method for rapid diagnosis of celiac disease
-
Last Update: 2020-06-07
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
celiac disease is an autoimmune disease that usually manifests itself as a nonspecific gastrointestinal symptomRecently, researchers at the University of Helsinki developed a novel diagnostic method called RFS (Rapid FRET Serum Diagnostics) for rapid on-site measurement of antibodies in patient samplesThis technology could revolutionise the status of serological diagnosis of microbial, autoimmune and allergic diseasesThe researchers have applied the new concept to the diagnosis of celiac disease, a celiac disease that most patients do not understandTherefore, doctors recommend screening for celiac disease in the population concerned: gastrointestinal symptoms or other autoimmune diseases, as well as patients with celiac disease and their first-level relativesScreening tests involve measuring disease-specific antibodies from blood samplesFor the study, researchers collected samples from 70 patients' celiacs from Kuopio University Hospital, half from children and half from adultsThe authors also collected control samples fromdonors ofHealth(http://The researchers measured the sample using new measurementmethods and compared the results with two current methods
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.